Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Overview
Stock Information
Nasdaq:
COCPPrice
Change
Mkt Cap
Volume
52 week Low/High
Day Low/High